Literature DB >> 21732038

Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19).

Ryosuke Shirasaki1, Haruko Tashiro1, Yoko Oka1, Toshihiko Sugao1, Tadashi Yamamoto1, Mayumi Yoshimi1, Nobu Akiyama1, Kazuo Kawasugi1, Naoki Shirafuji2.   

Abstract

The vascular endothelial growth factor (VEGF)-C system was analyzed in two cases of acute lymphocytic leukemia (ALL) with TCF3/PBX1 fusion to determine whether the VEGF-C system influences the growth of these ALL blasts. Bone marrow non-adherent mononuclear cells were prepared from the patients, and expressions of VEGFs and VEGF receptors (VEGFRs) were analyzed based on RNA and protein levels. Cell proliferation was also assayed with or without neutralizing antibodies to VEGFs. The patients' leukemic blasts expressed a significant amount of VEGF-C and VEGFR type-3. When anti-VEGF-C antibody was added to the blast cell cultures, cell proliferation was suppressed. These observations indicate that, in our ALL cases with TCF3/PBX1 fusion, VEGF-C autocrine stimulation plays an important role in the proliferation of ALL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732038     DOI: 10.1007/s12185-011-0889-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  27 in total

Review 1.  PbX marks the spot.

Authors:  Charles G Sagerström
Journal:  Dev Cell       Date:  2004-06       Impact factor: 12.270

Review 2.  Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.

Authors:  Pipsa Saharinen; Tuomas Tammela; Marika J Karkkainen; Kari Alitalo
Journal:  Trends Immunol       Date:  2004-07       Impact factor: 16.687

3.  Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells.

Authors:  Sanna-Maria Kivivuori; Sanna Siitonen; Kimmo Porkka; Kim Vettenranta; Riitta Alitalo; Ulla Saarinen-Pihkala
Journal:  Pediatr Blood Cancer       Date:  2007-04       Impact factor: 3.167

4.  VEGFR3 gene structure, regulatory region, and sequence polymorphisms.

Authors:  K Iljin; M J Karkkainen; E C Lawrence; M A Kimak; M Uutela; J Taipale ; K Pajusola; L Alhonen; M Halmekytö; D N Finegold; R E Ferrell; K Alitalo
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

5.  Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia.

Authors:  W Fielder; U Graeven; S Ergün; S Verago; N Kilic; M Stockschläder; D K Hossfeld
Journal:  Leukemia       Date:  1997-08       Impact factor: 11.528

6.  Acute myelogenous leukemia cells with the MLL-ELL translocation convert morphologically and functionally into adherent myofibroblasts.

Authors:  Haruko Tashiro; Mitsuho Mizutani-Noguchi; Ryosuke Shirasaki; Naoki Shirafuji
Journal:  Biochem Biophys Res Commun       Date:  2009-11-22       Impact factor: 3.575

Review 7.  The role of VEGF in normal and neoplastic hematopoiesis.

Authors:  Hans-Peter Gerber; Napoleone Ferrara
Journal:  J Mol Med (Berl)       Date:  2002-12-14       Impact factor: 4.599

Review 8.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

9.  The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.

Authors:  J D Mellentin; C Murre; T A Donlon; P S McCaw; S D Smith; A J Carroll; M E McDonald; D Baltimore; M L Cleary
Journal:  Science       Date:  1989-10-20       Impact factor: 47.728

10.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

Authors:  M P Kamps; C Murre; X H Sun; D Baltimore
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

View more
  2 in total

Review 1.  Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.

Authors:  Soumit K Basu; Scot C Remick; Manish Monga; Laura F Gibson
Journal:  Clin Exp Metastasis       Date:  2013-12-05       Impact factor: 5.150

2.  A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature.

Authors:  Carlos A Tirado; David Shabsovich; Lei Yeh; Sheeja T Pullarkat; Lynn Yang; Michael Kallen; Nagesh Rao
Journal:  Biomark Res       Date:  2015-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.